Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease ; volume:15 ; number:1 ; day:18 ; month:11 ; year:2024 ; pages:1-10 ; date:12.2024
Nature Communications ; 15, Heft 1 (18.11.2024), 1-10, 12.2024
- Urheber
-
Hofmann, Anna
Häsler, Lisa M.
Lambert, Marius
Kaeser, Stephan A.
Gräber-Sultan, Susanne
Obermüller, Ulrike
Kuder-Buletta, Elke
la Fougere, Christian
Laske, Christoph
Vöglein, Jonathan
Levin, Johannes Martin
Fox, Nick C.
Ryan, Natalie S.
Zetterberg, Henrik
Llibre-Guerra, Jorge J.
Perrin, Richard J.
Ibanez, Laura
Schofield, Peter R.
Brooks, William S.
Day, Gregory S.
Farlow, Martin R.
Allegri, Ricardo F.
Chrem Mendez, Patricio
Ikeuchi, Takeshi
Kasuga, Kensaku
Lee, Jae-Hong
Roh, Jee Hoon
Mori, Hiroshi
Lopera, Francisco
Bateman, Randall J.
McDade, Eric
Gordon, Brian A.
Chhatwal, Jasmeer P.
Jucker, Mathias
Schultz, Stephanie A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-52937-8
- URN
-
urn:nbn:de:101:1-2502042119451.900199452624
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hofmann, Anna
- Häsler, Lisa M.
- Lambert, Marius
- Kaeser, Stephan A.
- Gräber-Sultan, Susanne
- Obermüller, Ulrike
- Kuder-Buletta, Elke
- la Fougere, Christian
- Laske, Christoph
- Vöglein, Jonathan
- Levin, Johannes Martin
- Fox, Nick C.
- Ryan, Natalie S.
- Zetterberg, Henrik
- Llibre-Guerra, Jorge J.
- Perrin, Richard J.
- Ibanez, Laura
- Schofield, Peter R.
- Brooks, William S.
- Day, Gregory S.
- Farlow, Martin R.
- Allegri, Ricardo F.
- Chrem Mendez, Patricio
- Ikeuchi, Takeshi
- Kasuga, Kensaku
- Lee, Jae-Hong
- Roh, Jee Hoon
- Mori, Hiroshi
- Lopera, Francisco
- Bateman, Randall J.
- McDade, Eric
- Gordon, Brian A.
- Chhatwal, Jasmeer P.
- Jucker, Mathias
- Schultz, Stephanie A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Blood-based molecular biomarkers for Alzheimer’s disease
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
Blood-based molecular biomarkers for Alzheimer’s disease
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
Blood-based molecular biomarkers for Alzheimer’s disease
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease